CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Atypical hemolytic uremic syndrome and eculizumab therapy in children
Seong Heon Kim, Hye Young Kim, Su Young Kim
Clin Exp Pediatr. 2018;61(2):37-42.   Published online February 28, 2018
DOI: https://doi.org/10.3345/kjp.2018.61.2.37

Excel Download

Atypical hemolytic uremic syndrome and eculizumab therapy in children
Korean Journal of Pediatrics. 2018;61(2):37   Crossref logo
Link1 Link2 Link3

189 Eculizumab Therapy for Gemcitabine-Induced Atypical Hemolytic Uremic Syndrome
American Journal of Kidney Diseases. 2021;77(4):626   Crossref logo
Link1 Link2

Critical appraisal of eculizumab for atypical hemolytic uremic syndrome
Journal of Blood Medicine. 2016;39   Crossref logo
Link1

Resolution of ocular involvement with systemic eculizumab therapy in atypical hemolytic-uremic syndrome
Eye. 2013;27(8):997-998   Crossref logo
Link1 Link2 Link3

Eculizumab Therapy Leads to Rapid Resolution of Thrombocytopenia in Atypical Hemolytic Uremic Syndrome
Advances in Hematology. 2014;2014:1-7   Crossref logo
Link1 Link2 Link3

Anticomplement C5 therapy with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome
Translational Research. 2015;165(2):306-320   Crossref logo
Link1 Link2

Atypical hemolytic uremic syndrome in Brazil: clinical presentation, genetic findings and outcomes of a case series in adults and children treated with eculizumab
Clinical Kidney Journal. 2020;14(4):1126-1135   Crossref logo
Link1 Link2

COVID-19-associated atypical hemolytic uremic syndrome and use of Eculizumab therapy
Journal of Nephrology. 2021;35(1):317-321   Crossref logo
Link1 Link2 Link3

Case report of atypical hemolytic uremic syndrome with retinal arterial and venous occlusion treated with eculizumab
International Medical Case Reports Journal. 2015;235   Crossref logo
Link1

Complement C3 mutation causing atypical hemolytic uremic syndrome successfully treated with eculizumab
Hematology, Transfusion and Cell Therapy. 2021;43(3):364-367   Crossref logo
Link1 Link2